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Zinc induces epithelial to mesenchymal 
transition in human lung cancer H460 cells 
via superoxide anion-dependent mechanism
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Abstract 
Background: Epithelial to mesenchymal transition (EMT) has been shown to be a crucial enhancing mechanism in 
the process of cancer metastasis, as it increases cancer cell capabilities to migrate, invade and survive in circulating 
systems. This study aimed to investigate the effect of essential element zinc on EMT characteristics in lung cancer 
cells.
Methods: The effect of zinc on EMT was evaluated by determining the EMT behaviors using migration, invasion and 
colony formation assay. EMT markers were examined by western blot analysis. Reactive oxygen species (ROS) were 
detected by specific fluorescence dyes and flow cytometry. All results were analyzed by ANOVA, followed by indi-
vidual comparisons with post hoc test.
Results: The present study has revealed for the first time that the zinc could induce EMT and related metastatic 
behaviors in lung cancer cells. Results showed that treatment of the cells with zinc resulted in the significant increase 
of EMT markers N-cadherin, vimentin, snail and slug and decrease of E-cadherin proteins. Zinc-treated cells exhibited 
the mesenchymal-like morphology and increased cancer cell motility with significant increase of activated FAK, Rac1, 
and RhoA. Also, tumorigenic abilities of lung cancer cells could be enhanced by zinc. Importantly, the underlying 
mechanism was found to be caused by the ability of zinc to generate intracellular superoxide anion. Zinc was shown 
to induce cellular superoxide anion generation and the up-regulation of EMT markers and the induced cell migra-
tion and invasion in zinc-treated cells could be attenuated by the treatment of MnTBAP, a specific superoxide anion 
inhibitor.
Conclusion: Knowledge gains from this study may highlight the roles of this important element in the regulation of 
EMT and cancer metastasis and fulfill the understanding in the area of cancer cell biology.
Keywords: Zinc, Epithelial-to-mesenchymal transition, Superoxide anion, Lung cancer, Metastasis, Reactive oxygen 
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Background
Metastatic potential of lung cancer cells has been 
accepted to be an important cause of high rate of death 
worldwide [1]. Knowledge indicates that the process 
of cancer cell transition from epithelial to mesenchy-
mal phenotypes or epithelial to mesenchymal transition 
(EMT) plays a dominate role in facilitating metastasis 
and progression in many types of cancer [2–4]. EMT-
phenotypic cancer cells elicit highly metastatic potentials, 
such as aggressive migratory, invasive and increased tum-
origenicity [2–5]. During EMT, epithelial cells undergo 
remarkable morphological conversion from stone-like 
epithelial morphology to elongated-like mesenchymal 
morphology and the crucial hallmarks of EMT are the 
loss of E-cadherin, a cellular junction protein typically 
expressed in epithelial cells, and the increase of mesen-
chymal markers (e.g. N-cadherin, vimentin, snail and 
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slug) [2–5]. Zinc is a trace element implicated in many 
important cellular processes including structural, func-
tional and signaling of the cells [6, 7]. Zinc is detected in 
plasma at the concentrations ranging from 10 to 18 µM 
[6, 7] and the concentration of zinc in plasma or tissues 
is found to be elevated in pathological condition of can-
cer [8–11]. Importantly, evidence indicates that several 
zinc influx transporters such as Zrt/Irt-like protein (ZIP) 
6 [12], ZIP7 [13] and ZIP10 [14] were shown to be up-
regulated in cancer cells and their high levels correlate 
with aggressive behaviors and poor prognosis. Such data 
has suggested the roles of zinc in regulation of cancer cell 
biology. However, effects of zinc on the EMT process of 
cancer cells are largely unknown.
Recently, the involvement of ROS in EMT process 
has been continuously revealed [15–17]. Together with 
the fact that zinc has been shown to regulate cellular 
redox status of the cells [18–20], it is possible that zinc 
may affect the cancer cell behaviors via ROS-dependent 
mechanism. Indeed, the exogenous zinc has a capabil-
ity to induce ROS production via NADPH oxidase and 
mitochondria-dependent mechanism [18–20]. Zinc 
exposure was found to induce translocation of NADPH 
oxidase subunits to plasma membrane, which is the sig-
nature event for NADPH oxidase activation and such an 
event was inhibited by the addition of NADPH oxidase 
inhibitor [7, 19, 20]. Together, we hypothesize that zinc 
may affect the process of EMT in lung cancer cells. Also, 
we attempt to clarify the mechanisms involved in zinc-
induced EMT. The findings from this study could help 
fulfill the understanding in tumor cell biology and could 
provide important information useful for zinc manage-
ment in cancer patients.
Methods
Cells and reagents
Human lung cancer epithelial H460 cell was obtained 
from the American Type Culture Collection (ATCC, 
Manassas, VA). H460 cell was cultured in RPMI 
1640 medium in a 5  % CO2 environment at 37  °C. The 
media was supplemented with 2  mM l-glutamine, 
10  % fetal bovine serum and 100  units/ml of penicil-
lin/streptomycin (Gibco, Gaithersburg, MA, USA). 
Zinc sulfate, dimethyl sulfoxide (DMSO), 2,7-dichloro-
fluorescein diacetate (DCFH2-DA), dihydroethidium 
(DHE), hydroxyphenyl fluorescein (HPF), DMNQ 
(2,3-dimethoxy-1,4-naphthoquinone),3-(4,5-Dimethylth-
iazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and 
Hoechst 33342 were obtained from Sigma Chemical, Inc. 
(St. Louis, MO, USA). Mn (ΙΙΙ) tetrakis (4-benzoic acid) 
porphyrin chloride (MnTBAP) was obtained from Cal-
biochem (San Diego, CA, USA). Antibodies for N-cad-
herin, E-cadherin, vimentin, snail, slug, phosphorylated 
FAK (Y397), FAK, and β-actin and peroxidase-labeled 
secondary antibodies were obtained from Cell Signaling 
Technology, Inc. (Denver, MA). Mouse monoclonal anti-
bodies for active Rho-GTP and Rac1-GTP were obtained 
from NewEast Biosciences (Malvern, PA, USA). Immo-
bilon Western chemiluminescent HRP substrate was 
obtained from Millipore, Corp (Billerica, MA, USA) and 
Thermo Fisher Scientific Inc. (Rockfort, IL, USA).
Cytotoxicity assay
Cell viability was determined by MTT colorimetric assay. 
Briefly, cells in 96-well plate were incubated with 500 μg/
ml of MTT for 4  h at 37  °C. The supernatant was then 
removed and dimethylsulfoxide (DMSO) was added to 
dissolve the formazan product. The intensity was spec-
trophotometrically measured at 570 nm using an ELISA 
reader (Anthros, Durham, NC, USA). All analyses were 
performed in at least three independent replicate cul-
tures. The optical density ratio of treated to non-treated 
control cells was calculated and presented in terms of 
relative cell viability.
Apoptosis assay
Apoptotic cell death was detected by Hoechst 33342 
staining. After specific treatments, cells were stained 
with 10 µM of the Hoechst 33342 for 30 min at 37 °C. The 
apoptotic cells having condensed chromatin and/or frag-
mented nuclei stained by Hoechst 33342 were visualized 
and scored under a fluorescence microscope (Olympus 
IX51 with DP70).
Cell morphology characterization
Cell morphology was investigated by seeding the cells 
at a density of 5 × 104 cells/well onto a 12-well plate for 
48 h. The cells were treated with various concentrations 
of zinc sulfate for 24 h. The cells were then washed with 
PBS, fixed with 4 % paraformaldehyde in PBS for 10 min 
at 37 °C, rinsed three times with PBS, and mounted with 
50  % glycerol. Cell morphology was then assessed by a 
phase contrast microscope (Eclipse Ti-U, Nikon, Tokyo, 
Japan).
Immunofluorescence
Cells were seeded at a density of 1 × 105 cells/well onto 
coverslips in six-well plate and incubated overnight. After 
the treatment, the cells on coverslips were fixed with 4 % 
paraformaldehyde for 30  min and permeabilized with 
0.1 % Triton-X for 20 min. Thereafter, the cells were incu-
bated with 3 % bovine serum albumin (BSA) for 30 min to 
prevent nonspecific binding. The cells were washed and 
incubated with rabbit anti-Vimentin antibody for 1 h at 
room temperature. Primary antibody was removed and 
the cells were washed and subsequently incubated with 
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Alexa Fluor 488 (Invitrogen) conjugated goat anti-rabbit 
IgG (H + L) secondary antibody for 1 h at room tempera-
ture. Samples were washed with PBS then visualized and 
imaged by fluorescence microscope (Olympus IX 51 with 
DP70, Olympus America Inc., Center valley, PA).
Western blot analysis
After specific treatments, cells were incubated in lysis 
buffer containing 20 mM Tris–HCl (pH 7.5), 1 % Triton 
X-100, 150  mM sodium chloride, 10  % glycerol, 1  mM 
sodium orthovanadate, 50 mM sodium fluoride, 100 mM 
phenylmethylsulfonyl fluoride, and a protease inhibitor 
cocktail (Roche Molecular Biochemicals) for 90  min on 
ice. The cell lysates were collected, and the protein con-
tent was determined using the BCA protein assay kit 
(Thermo scientific, IL, USA). Equal amounts of proteins 
from each sample (60  μg) were denatured by heating at 
95 °C for 5 min with Laemmli loading buffer and subse-
quently loaded onto a 10 % SDS-PAGE. After separation, 
proteins were transferred onto 0.45  μM nitrocellulose 
membranes (Bio-Rad, Hercules, CA). The transferred 
membranes were blocked for 1 h in 5 % nonfat dry milk 
in TBST (25 mM Tris–HCl pH 7.5, 125 mM NaCl, and 
0.05 % Tween 20) and incubated with the appropriate pri-
mary antibodies at 4 °C overnight. Then, the membranes 
were washed twice with TBST for 10 min and incubated 
with horseradish peroxidase-labeled isotype-specific 
secondary antibodies for 2  h at room temperature. The 
immune complexes were detected by enhancement with 
chemiluminescence substrate (Supersignal West Pico; 
Pierce, Rockfore, IL) and quantified the level of proteins 
using imageJ software.
Migration assay
Migration was determined by wound healing and tran-
swell assays. For the wound healing assay, a monolayer of 
cells was cultured in a 96-well plate, and a wound space 
was made with a 1-mm-wide tip. After rinsing with PBS, 
the cell monolayers were incubated with the indicated 
treatments and allowed to migrate for 24 h. Micrographs 
were taken under a phase contrast microscope (Olympus 
DP70, Melville, NY), and the wound spaces were meas-
ured using Olympus DP controller software. Quantitative 
analysis of cell migration was performed using an average 
wound space from those random fields of view, and the 
percentage of change in the wound space was calculated 
using the following formula: % change =  (average space 
at time 0 h) − (average space at time 24 h)/(average space 
at time 0 h) × 100. Relative cell migration was calculated 
by dividing the percentage change in the wound space of 
treated cells by that of the control cells in each experi-
ment. For the transwell assay, the cells were seeded at a 
density of 5 × 104 cells/well onto the upper chamber of 
a transwell (8 µm pore size) in a 24-well plate in serum-
free medium and incubated with various concentrations 
of zinc. RPMI medium containing 10  % FBS was added 
to the lower chamber. Following the incubation, the non-
migrated cells in the upper chamber were removed by 
cotton-swab wiping, and the cells that migrated to the 
underside of the membrane were stained with 10 µg/ml 
of Hoechst 33342 for 10  min and visualized and scored 
under a fluorescence microscope (Olympus IX51 with 
DP70).
Invasion assay
An invasion assay was performed using a 24-well tran-
swell unit with polycarbonate (PVDF) filters (8 µm pore 
size). The membrane was coated with 0.5 % matrigel on 
the upper surface of the chamber overnight at 37  °C in 
a humidified incubator. The cells were plated at a den-
sity of 2 × 104 cells per well into the upper chamber of 
the transwell unit in serum-free medium. Medium con-
taining 10 % FBS was added to the lower chamber of the 
unit. After incubation with specific test agents for 24 h at 
37 °C, the medium in the upper chamber was aspirated, 
and the cells on the upper side of the membrane were 
removed with a cotton swab. The cells that invaded to the 
underside of the membrane were stained with 10 µg/ml 
of Hoechst 33342 for 10 min, visualized and scored under 
a fluorescence microscope (Olympus IX51 with DP70).
In vitro 3D tumorigenesis assay
In vitro 3D tumorigenesis was performed in a matrigel-
coated 96-well plate. A plate was coated with 0.5 % aga-
rose and left for solidification. The cells were suspended 
in culture medium containing 4  % matrigel and various 
concentrations of zinc, and plated at a density of 3 × 102 
cells/well onto a agarose-coated plate. Medium contain-
ing various concentrations of zinc were replaced every 
3 days. After 10 days, the cells were visualized and scored 
by image analyzer under microscope (Olympus IX51 
with DP70). Whole area of each well was captured in one 
picture and the colonies with more than 25 µm of diam-
eter were quantified.
ROS detection
Intracellular ROS were determined by fluorescence 
microplate reader and by flow cytometry using the ROS-
specific probe, superoxide anions, hydrogen peroxide 
and hydroxyl radicals were determined by DHE, DCFH2-
DA and HPF, respectively. For fluorescence microplate 
reader, cells were seeded overnight in 96-well plate. 
Before zinc treatment cells were incubated with 10  μM 
of dihydroethidium (DHE), dichlorofluorescein diac-
etate (DCFH2-DA) or hydroxyphenyl fluorescein (HPF) 
for 30  min at 4  °C, after which they were washed and 
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treated with various concentrations of zinc (0–50  µM) 
for 1 and 3 h. After incubation, the fluorescence intensity 
was immediately analyzed by fluorescence microplate 
reader (SpectraMax M5, Molecular Devices Corp., Sun-
nyvale, CA, USA) using a 488-nm excitation beam and a 
610-nm band-pass filter for DHE, using a 480-nm exci-
tation beam and a 530-nm band-pass filter for detecting 
DCF fluorescence or using a 490-nm excitation beam 
and a 515-nm band-pass filter for HPF. For flow cytom-
etry, cells were seeded overnight in six-well plate. Before 
zinc treatment cells were incubated with 10 μM of DHE, 
DCFH2-DA or HPF for 30 min at 4 °C, after which they 
were washed and treated with 50  µM of zinc for 1 and 
3 h. After incubation, cells were washed, re-suspended in 
phosphate-buffered saline (PBS), and immediately ana-
lyzed for fluorescence intensity by FACScan flow cytom-
eter (Beckton Dickinson, Rutheford, NJ) using a 488-nm 
excitation beam and a 610-nm band-pass filter for DHE, 
using a 480-nm excitation beam and a 530-nm band-pass 
filter for detecting DCF fluorescence or using a 490-nm 
excitation beam and a 515-nm band-pass filter for HPF. 
Mean fluorescence intensity was quantified by CellQuest 
software (Becton–Dickinson) analysis of the recorded 
histograms. Relative fluorescence was calculated as a 
ratio of the treated to the non-treated control fluores-
cence intensity.
Statistical analysis
All treatment data were normalized to non-treated con-
trols. Data are expressed as the mean ±  SD from three 
or more independent experiments. Multiple compari-
sons were examined for significant differences of multiple 
groups, using analysis of variance (ANOVA), followed by 
individual comparisons with post hoc test. Statistical sig-
nificance was set at p < 0.05.
Results
Effects of zinc on viability of human lung cancer H460 cells
In order to investigate the effect of zinc on EMT pheno-
types in human lung cancer cells, we first evaluated the 
non-cytotoxic concentrations of zinc. Cells were cultured 
in the presence or absence of zinc (0–100 µM) for 24 h, 
and cell viability was determined by MTT assay at 24 h. 
The results indicated that treatment of the cells with zinc 
at the concentrations ranging from 5 to 50 µM caused no 
significant cytotoxicity (Fig. 1a). The significant decrease 
in cell viability was first detected in response to 100 µM 
of zinc treatment with approximately 86  % of the cells 
remaining viable.
Proliferative effect of zinc at above concentrations 
was further evaluated by treating the cells with zinc for 
0–72 h. Figure 1b indicates that zinc at the concentrations 
of 0–50 µM had no inductive effect on cell proliferation. 
To confirm the effect of zinc on cell toxicity, cells were 
similarly treated with zinc for 24  h, and apoptosis was 
evaluated by Hoechst 33342 staining assay. Figure  1c, d 
show that apoptotic cells containing condensed and/
or fragmented nuclei were not detectable in response to 
zinc treatment at the concentrations of 5–50 µM.
Zinc induces epithelial to mesenchymal transition 
in human lung cancer H460 cells
The effect of zinc on EMT in H460 cells was next inves-
tigated. The alteration of cell morphology as well as hall-
marks of EMT were used to monitor the effect of zinc on 
EMT process in lung cancer cells. Cells were treated with 
zinc at non-toxic concentrations for 24 h. The morphol-
ogy of the cells was captured and presented in Fig. 2a The 
results showed that the zinc-treated cells exhibited mor-
phology of mesenchymal-like cells with the elongated 
shape and loss of cell polarity. These results also sug-
gested that the mesenchymal-like morphology is some-
how dose-dependent as the more elongated cells could 
be found in the cells treated with high concentrations of 
zinc. In addition, the expression of mesenchymal marker 
vimentin was significantly increased in response to zinc 
treatment (Fig. 2b).
The switch of E-cadherin to N-cadherin and increase 
of EMT proteins including vimentin, slug, and snail have 
been shown to be important hallmarks of EMT in can-
cer cells [2–5]. We next determined such cellular EMT 
markers in the lung cancer cells treated with zinc by 
western blot analysis. Obviously, treatment of the cells 
with zinc could reduce E-cadherin in a dose-depend-
ent manner. Together with the fact that the significant 
increase of N-cadherin was found when treating the cells 
with 5–50 µM of zinc, these data strongly indicated that 
zinc could be able to mediate E-cadherin to N-cadherin 
switching in these cells. In addition, the upstream tran-
scription factors of EMT namely snail and slug were 
determined in the zinc-treated cells. These factors were 
shown to bind to E-box elements in the promoter region 
of E-cadherin, resulting in the transcriptional repres-
sion of E-cadherin and induction of mesenchymal mark-
ers [2–4]. Figure  2c, d indicate that zinc significantly 
increased the levels of slug and snail. Also, the EMT pro-
tein vimentin was found to be induced by zinc. Taken 
together, our results suggested that zinc could induce 
EMT in lung cancer cells.
Zinc facilitates H460 cell migration and invasion
One important phenotype of EMT cells is the increase in 
cell motility. Studies have demonstrated that EMT could 
enhance aggressiveness of tumor cells by increasing 
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their ability to migrate and invade [2–4]. To evaluate 
the effect of zinc on cancer cell motility, cells were left 
untreated or pretreated with zinc at non-toxic concen-
trations for 24  h and subjected to migration and inva-
sion assays as described in “Methods” section. Wound 
healing migratory assay showed that zinc significantly 
facilitated migratory activity of the cells with the relative 
cell migration increased approximately 1.3- to 1.8-fold in 
comparison to that of non-treated control cells (Fig. 3a, 
b). Also, the transwell migration assay was performed to 
confirm the migratory effect of zinc. Figure 3c shows that 
zinc treatment significantly increased the number of cells 
passed through the membrane of well, suggesting that 
such element induced cell migration.
Next, we performed experiments to test the abil-
ity of the cancer cells in invading through matrigel. The 
transwell was pre-coated with matrigel and the zinc-
treated cells were seeded on top. The cells were allowed 
to invade for 24 h and the invaded cells at the lower part 
of the membrane were determined. Figure 3d shows that 
zinc significantly promoted the invasion of H460 cells in 
a dose-dependent manner.
Enhanced tumor cell migration and invasiveness are 
shown to be down-stream behaviors of FAK signal [21–
24]. We next determined the effect of zinc treatment on 
motility regulatory proteins including FAK, activated 
(phosphorylated at Try397) FAK, active forms of RAC1, 
and RhoA by western blot analysis. The results showed 
that treatment of the cells with 0–50 µM of zinc for 24 h 
dramatically increased the activation of FAK (Fig. 3e, f ). 
Also, its down-stream functioning proteins active Rac1 
and RhoA were found to increase, accordingly. These 
Fig. 1 The cytotoxic and proliferative effects of zinc on lung cancer H460 cells. a Effect of zinc on cell viability. Cells were treated with various con-
centrations of zinc (0–100 µM) for 24 h. Percentage of cell viability was determined by the MTT assay. Values are means of the independent triplicate 
experiments ± SD. *p < 0.05 versus non-treated control. b Proliferative effect of zinc on H460 cells. Cells were treated with zinc (0–50 µM) for 0–72 h 
and analyzed by MTT assay. c Apoptotic cells were detected by Hoechst 33342 staining after 24 h of zinc treatment. White arrow indicates the 
apoptotic cells having condensed chromatin and/or fragmented nuclei. Values are means of independent triplicate experiments ± SD. *p < 0.05 
versus non-treated control. d Nuclear morphology of the cells stained with Hoechst 33342 and visualized under a fluorescence microscope; scale 
bar 100 µm
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Fig. 2 Effect of zinc on epithelial to mesenchymal transition (EMT). Cells were treated with various concentrations of zinc (0–50 µM) for 24 h. a Cells 
morphology was examined by phase-contrast microscope; scale bar 100 µm. b Expression of vimentin was analyzed by immunofluorescence stain-
ing; scale bar 100 µm. c The expression levels of EMT protein markers were determined by western blotting. The blots were re-probed with β-actin 
to confirm equal loading of the samples. d The blots were quantified by densitometry and mean data from three independent experiments were 
normalized to the results. The bars are the mean ± SD of independent triplicate experiments. *p < 0.05 versus untreated control
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results suggested that zinc treatment increase EMT-asso-
ciated cell behaviors trough FAK-dependent pathway.
Zinc enhances tumorigenicity in human lung cancer H460 
cells
Having shown that zinc could enhance cell migration 
and invasion, we next tested whether zinc may augment 
the ability of cancer cell to initiate a new tumor. It is well 
known that the EMT process facilitate tumor formation 
at the metastatic site [25–27] and this potential is respon-
sible for cancer progression [25–27]. Previous studies 
have shown that in vitro 3D tumorigenesis assay reflexes 
ability of the cancer cells in in vivo cancer condition [28]. 
Cells were left un-treated or pre-treated with various 
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concentrations of zinc (0–50 µM) for 24 h and subjected 
to tumorigenesis assay as described in “Methods” sec-
tion. After 10  days of 3D culturing, the colony number 
and diameter were determined. Figure 4 shows that zinc 
treatment enhances tumorigenic ability of the lung can-
cer cells as indicated by the significant increase in the 
number and size of colonies in zinc-treated groups. The 
number of colonies increased approximately 1.38- and 
1.76-fold in response to zinc at 25 and 50  µM, respec-
tively (Fig. 4b).
Zinc induces intracellular superoxide anion generation 
in H460 cells
Studies have demonstrated the roles of ROS on cancer 
EMT phenotypes [15–17]. Because zinc has been previ-
ously shown to affect the redox balance of the cells and 
exhibit the pro-oxidant activity in normal and cancer 
cells [7, 18–20], we next evaluated whether the effect of 
zinc in regulation of EMT in these lung cancer cells is 
through ROS-dependent mechanism. To examine the 
specific ROS levels induced by zinc, cells were incu-
bated with various ROS specific probes as mentioned 
in “Methods” section for 30  min before treatment with 
0–50  µM zinc and intracellular ROS levels were deter-
mined by flow cytometry and fluorescence microplate 
reader. Figure 5a, d show that zinc significantly increased 
cellular superoxide anion, while it had minimal effect 
on hydrogen peroxide (Fig.  5b, e) and hydroxyl radical 
(Fig. 5c, f ). Consistent with microplate reader determina-
tion, flow cytometric analysis revealed that intracellular 
superoxide anion significantly increased up to twofold 
in response to zinc treatment (Fig.  5g) and zinc had no 
detectable effect on hydrogen peroxide and hydroxyl 
radical (Fig. 5h, i). We further confirmed the superoxide 
Fig. 4 Zinc enhances tumorigenic potential of H460 lung cancer cells. a H460 cells were pre-treated with zinc (0–50 µM) for 24 h. The treated cells 
were subjected to 3D tumorigenesis assay. The cells were suspended in RPMI medium containing 4 % matrigel and zinc (0–50 µM) and plated onto 
agarose-coated plate. After 10 days, colonies were visualized under microscope; scale bar 500 µm. b Value was represented as average diameter 
and number of colonies in each field relatively to control cells using image analyzer. Values are means of independent triplicate experiments ± SD. 
*p < 0.05 versus untreated control
(See figure on previous page.) 
Fig. 3 Effect of zinc on lung cancer cell migration and invasion. Cells were pre-treated with zinc (0–50 µM) for 24 h. The treated cells were sub-
jected to migration and invasion assays. a For wound healing assay, the confluent monolayers of the cells were wounded by using a 1 mm-wide 
tip and cultured with the medium containing indicated treatments. After 24 h of incubation, wound spaces were analyzed and represented as a 
relative migration level. b The relative migration level was determined by comparing the relative change of zinc-treated cells to untreated control 
cells. Values are means of independent triplicate experiments ± SD. *p < 0.05 versus untreated control. c For transwell migration assay, migratory 
cells were stained with Hoechst 33342 for 30 min, determined under a fluorescence microscope and represented as average number of migra-
tory cells in each field relatively to control cells. d Cell invasion was evaluated using a transwell coated with matrigel as described under “Methods” 
section. After 24 h, the cells that invaded across the membrane were stained with Hoechst 33342 for 30 min and visualized under a fluorescence 
microscope. Value was represented as average number of invaded cells in each field relatively to control. Values are means of independent triplicate 
experiments ± SD. *p < 0.05 versus untreated control. e The expression levels of motility-regulatory proteins were determined by western blotting. 
The blots were re-probed with β-actin to confirm equal loading of the samples. f The blots were quantified by densitometry and mean data from 
three independent experiments were normalized to the results. The bars are the mean ± SD of independent triplicate experiments. *p < 0.05 versus 
untreated control
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anion-inducing effect of zinc using specific superoxide 
anion inhibitor MnTBAP. Results indicated that treat-
ment with the zinc caused the superoxide anion up-reg-
ulation in the cells and such event could be abolished by 
the addition of MnTBAP, confirming that the major ROS 
induced by zinc treatment in our system was superoxide 
anion (Fig. 5j, k).
Zinc mediates EMT phenotypes in lung cancer cells 
through superoxide anion‑dependent mechanism
In order to investigate the role of superoxide anion on 
EMT induction, cell morphology, EMT markers, migra-
tory behaviors, and colony formation were evaluated 
in the cells treated with zinc and specific inhibitor of 
superoxide anion. Cells were cultured in the presence 
or absence of MnTBAP for 1  h prior to zinc treatment 
and EMT phenotypes were determined. Also, to clarify 
role of superoxide anion, the superoxide anion inducer 
DMNQ was used. The results show that treatment of the 
cells with DMNQ or zinc alone was able to switch the 
morphology of lung cancer cells from epithelial to fibro-
blast-liked mesenchymal feature (Fig.  6a). Addition of 
MnTBAP to the zinc-treated cells could be able to atten-
uate such morphologic transformation.
Immunocytochemistry showed the increased vimen-
tin found in DMNQ- and zinc- treated cells. And the 
increased vimentin signal induced by zinc was sup-
pressed by the addition of MnTBAP (Fig.  6b). Consist-
ently, the results of western blot analysis revealed that 
EMT markers including N-cadherin, vimentin, snail, and 
slug were found to be significantly increased in response 
to DMNQ and zinc treatment and such phenomenon 
could be reversed by the addition of MnTBAP (Fig. 6c, d).
As DMNQ was used as a superoxide anion donor, the 
intracellular superoxide anion generated by DMNQ was 
determined. Cells were incubated with DHE as men-
tioned in “Methods” section for 30 min and treated with 
5 µM of DMNQ. DHE intensity was determined by flow 
cytometry. The result indicated the 1.5-fold superoxide 
induction in DMNQ-treated cells as shown in Fig. 6e.
The migration and invasion of the cells were further 
evaluated. The results were consistent with the expres-
sion levels of EMT proteins that DMNQ and zinc could 
be able to induce cell migration and invasion and such 
inductions could be abolished by superoxide anion inhib-
itor (Fig. 7a–d). Also, the colony size and number which 
were increased in response to zinc treatment were found 
to be significantly attenuated by the treatment of MnT-
BAP (Fig. 7e, f ). Taken together, these results pointed out 
that zinc induces EMT process, migratory behaviors, and 
tumorigenic potential in the lung cancer cells via super-
oxide anion-dependent mechanism.
Discussion
Accumulating data have guided for a long time that zinc, 
an essential element composition of numerous proteins 
[6–8, 29], may play important parts on the basis of can-
cer cell biology. The plasma zinc level was found to be 
significantly elevated in certain cancer tissues [8–11]. 
Zinc-containing compounds seem to be associated with 
carcinogenesis in lung cancer other cancers [30, 31]. In 
detail, zinc chromate was found to increase cytotoxicity, 
chromosome damage and DNA double strand breaks in 
human lung epithelial cells, suggesting the roles of zinc-
containing compounds in cell toxicity and carcinogenesis 
[30]. Besides, the increase of zinc influx transporters such 
as ZIP6 [12], ZIP7 [13] and ZIP10 [14] has been linked 
to the aggressive behaviors and poor prognosis of breast 
cancer [12–14, 32].
Until recently, the knowledge of zinc on the molecular 
mechanisms of cancer metastasis is still not fully under-
stood especially those regulating EMT. EMT is consid-
ered a critical augmenting process of cancer metastasis 
as it facilitates cancer dissemination in many ways [2–4]. 
In the process of EMT, cellular phenotypes are altered 
together with the distinguished expressions of protein 
markers being changed from epithelial toward mesen-
chymal types [2–5]. The process facilitates the loss of cell 
adhesion, increases motility, and survival in detached 
condition [2–5]. During EMT, an elongated fibroblast-
like morphology of the cells is frequently observed. 
However, indicators like the switching between E-cad-
herin and N-cadherin, as well as EMT transcription fac-
tors snail and slug are more acceptable as hallmarks of 
EMT [2–5]. In particular, lung cancer H460 cells were 
shown to undergo EMT in response to various stimuli 
[33, 34]. EMT features of H460 cells were characterized 
by (i) the change of cell morphology from epithelial to 
(See figure on next page.) 
Fig. 5 Zinc induces intracellular superoxide anion generation in H460 cells. a–i The cells were incubated with specific ROS probes, namely, DHE, 
DCFH2-DA, or HPF at 4 °C for 30 min prior to the treatment with zinc (0–50 µM) for 0–3 h and the fluorescence intensity was analyzed by a micro-
plate reader and flow cytometry. Mean intensity was normalized to untreated control cells and represented as relative ROS levels. Values are means 
of independent triplicate experiments ± SD. *p < 0.05 versus untreated control. j–k The cells were incubated with DHE at 4 °C for 30 min prior to 
pre-treatment with 50 µM MnTBAP (superoxide anion inhibitor) for 1 h in the presence or absence of zinc (50 µM) for 3 h and the fluorescence 
intensity was analyzed by a microplate reader and flow cytometry. Mean intensity was normalized to untreated control cells and represented as 
relative ROS levels. Values are means of independent triplicate experiments ± SD. *p < 0.05 versus untreated control
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fibroblast-liked mesenchymal shape, (ii) the increased 
EMT markers N-cadherin, vimentin, snail, and slug, 
together with the reduction of epithelial marker E-cad-
herin, and (iii) EMT behaviors, including increased 
migration, invasion and tumorigenic potential [33–38]. 
In consistent with such studies, our results showed that 
zinc-treated lung cancer cells displayed the elongated 
mesenchymal-like shape with the significant increase of 
EMT markers namely N-cadherin, vimentin, snail and 
slug (Fig. 2). Also, we found that the E-cadherin was dra-
matically reduced in response to zinc treatment.
Previous studies indicated that EMT facilitates the cell 
motility by decreasing cell–cell interaction via E-cad-
herin, while increases in N-cadherin-mediated steady-
state of active Rac1 [21, 22]. Similar to N-cadherin, 
Vimentin was shown to increase FAK and Rac1 activi-
ties [23, 24]. We found that zinc could induce EMT, 
resulting in the increase of cancer cell migration and 
invasion. The proteins regulating cell motility like FAK, 
RhoA and Rac1 were found to be activated in response 
to such up-stream signals (Fig. 3). Also, the EMT event 
was shown to be a key factor that enhances ability of 
cancer cells to metastasis by increasing the survival 
after cell detachment and ability to form tumors [34, 
39]. It has been previously reported that the ability of 
cancer cells in forming new tumor can be enhanced 
by EMT as a result from snail augmentation [25–27]. 
We have supported this fact by the demonstration that 
treatment of the cells with zinc induced EMT with sig-
nificant increase of snail increased number and size of 
tumor colonies in 3D culturing anchorage-independent 
condition (Fig. 4).
In the previous work, we have reported that the widely 
used chemical agent triclosan could be able to enhance 
EMT and aggressive behaviors in anoikis-resistant lung 
cancer cells [34]. However, role of endogenous element 
zinc on such effects has not been clarified. This current 
study has reported for the first time that zinc signifi-
cantly induced EMT and tumorigenic potential in lung 
cancer cells through the enhancement of cellular super-
oxide anion level. Superoxide anion has been implicated 
in various biological and pathological processes [40–42]. 
Evidence has shown that the level of superoxide anion is 
frequently upregulated in cancer cells and regulates can-
cer cell proliferation, migration and metastasis [42–46]. 
Interestingly, we have first revealed the role of such a 
specific ROS in regulation of EMT in cancer cells, as the 
EMT could be induced by addition of superoxide anion 
generator (Figs.  6, 7). The EMT mediated by zinc treat-
ment was abolished by the superoxide anion inhibitor. 
These findings not only provide the evidence of endoge-
nous element in regulation of cancer biology, but also add 
the fact involving specific ROS roles on EMT process of 
cancer cells. The involvement of ROS signaling on cancer 
metastasis and EMT has garnered increasing attentions 
[15–17, 47]. The EMT-related transcription factor snail 
was shown to be sensitive to the balance of cellular ROS 
status [47, 48].
Interestingly, zinc was previously addressed to have 
the potential to interfere with redox status of the cells by 
(See figure on next page.) 
Fig. 7 Zinc promotes EMT-related cancer aggressive behaviors of H460 cells through superoxide anion-dependent mechanism. a For cell migra-
tion, cells were incubated with 5 µM DMNQ (superoxide anion inducer) or 50 µM MnTBAP (superoxide anion inhibitor), in the presence or absence 
of zinc (50 µM) for 24 h before the assay. After 24 h of incubation, wound spaces were analyzed and represented as a relative migration level. b 
The relative cell migration was determined by comparing the relative change of those in untreated cells. c–d For invasion, cells were incubated 
with 5 µM DMNQ or 50 µM MnTBAP in the presence or absence of zinc (50 µM) for 24 h and cells invasion was evaluated using a transwell coated 
with matrigel as described under “Methods” section. Value was represented as average number of invaded cells in each field relatively to control. 
e For tumorigenicity, cells were incubated with 5 µM DMNQ or 50 µM MnTBAP in the presence or absence of zinc (50 µM) for 24 h prior to grow 
in matrigel. After 10 days, colonies were visualized under microscope; scale bar 500 µm. f Value was represented as average diameter and number 
of colonies in each field relatively to control cells using image analyzer. Values of all experiments are means of independent triplicate experi-
ments ± SD. *p < 0.05 versus untreated control. #p < 0.05 versus 50 µM zinc-treated cells
(See figure on previous page.) 
Fig. 6 Effect of superoxide anion on EMT. a H460 cells were incubated with 5 µM DMNQ (superoxide anion inducer) or 50 µM MnTBAP (superoxide 
anion inhibitor), in the presence or absence of zinc (50 µM) for 24 h prior to morphology examination using phase contrast microscope; scale bar 
100 µm. b Cells were treated with 5 µM DMNQ or 50 µM MnTBAP in the presence or absence of zinc (50 µM) for 24 h. Expression of vimentin were 
analyzed by immunofluorescence staining; scale bar 100 µm. c Cells were treated with 5 µM DMNQ or 50 µM MnTBAP, in the presence or absence of 
zinc (50 µM) for 24 h. The cells were collected and analyzed for EMT markers by western blotting. The blots were re-probed with β-actin to confirm 
equal loading. d The immunoblot signals were quantified by densitometry and mean data from independent experiments were normalized to 
the results. The bars are the mean ± SD of independent triplicate experiments. *p < 0.05 versus untreated control cells. #p < 0.05 versus 50 µM 
zinc-treated cells. e Cells were incubated with DHE at 4 °C for 30 min prior to the treatment of DMNQ (5 µM) or zinc (50 µM), and the fluorescence 
intensity was analyzed by flow cytometry at 3 h. Mean intensity was normalized to untreated control cells and represented as relative superoxide 
anion levels. Values are means of independent triplicate experiments ± SD. *p < 0.05 versus untreated control
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inducing oxidative stress [18–20]. In neurons, intracel-
lular zinc is shown to trigger the ROS production during 
the process of neuron damage [49, 50]. Besides, the eleva-
tion of intracellular zinc was shown to induce superoxide 
anion production from the function of 12-lipoxygenase 
(12-LOX) enzyme [49, 50]. Interestingly, zinc was demon-
strated to promote Hep-2 cancer cell apoptosis by stimu-
lating oxidative stress [18]. Our results showed that zinc 
could increase superoxide anion in the human lung can-
cer cells (Fig. 5). The superoxide anion in such cases was 
suggested to be generated through NADPH oxidase sys-
tem [19, 20]. Although studies have indicated that hydro-
gen peroxide can also mediate EMT in human malignant 
mesothelioma and human ovarian cancer cells [51, 52], 
treatment of the zinc in our system caused no effect on 
the cellular level of hydrogen peroxide (Fig. 5). We further 
investigated the role of superoxide anion on EMT using 
the superoxide anion inducer DMNQ. DMNQ is known 
to induce superoxide anion generation via NADPH oxi-
dase activity [53, 54]. We found that treatment of the cells 
with DMNQ significantly increased the protein hallmarks 
of EMT as well as metastatic potentials (Figs. 6, 7). Such 
roles of superoxide anion on EMT were linked with the 
results of zinc, suggesting that zinc mediates the EMT 
phenotypes via the production of cellular superoxide 
anion. These results were confirmed by the ROS inhibitory 
experiment. Addition of MnTBAP in the zinc-treated cells 
was shown to abolish superoxide anion induction as well 
as EMT phenotypes in response to zinc treatment (Figs. 6, 
7), strongly indicating that the effect of zinc on EMT was 
regulated via superoxide-dependent mechanism.
Conclusions
In summary, our finding provided the evidence that zinc 
played a key role in the regulation of EMT and metastatic 
behaviors. Such inductions of the aggressive EMT pheno-
types were dependent on zinc-induced superoxide anion 
generation as indicated in the summarized schematic fig-
ure (Fig. 8). This information helps fulfill the knowledge 
regarding the role of zinc in tumor cell biology.
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DCFH2-DA: 2,7-dichlorofluorescein diacetate; DHE: dihydroethidium; DMNQ: 
2,3-dimethoxy-1,4-naphthoquinone; EMT: epithelial to mesenchymal transi-
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adenine dinucleotide phosphate; Rac1: Ras-related C3 botulinum toxin 
subdtrate 1; RhoA: Ras homolog gene family member A; ROS: reactive oxygen 
species; ZIP: Zrt/Irt-like protein.
Fig. 8 Schematic mechanism of zinc-induced EMT in lung cancer cells. Zinc exposure was found to increase the intracellular superoxide anion 
and induce EMT phenotypes in lung cancer cells by up-regulating of EMT markers (snail, slug, N-cadherin and vimentin) and down-regulating 
of E-cadherin protein. Reorganization of adhesion and cytoskeleton proteins resulted in mesenchymal morphology and facilitated aggressive 
behaviors, including migration, invasion and tumorigenicity in zinc-treated cells. Importantly, zinc-induced lung cancer EMT was clearly inhibited by 
superoxide anion inhibitor (MnTBAP), suggesting that the induction of the aggressive EMT phenotypes was dependent on zinc-induced superoxide 
anion generation
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